SCHEMBL31358629

SCHEMBL31358629

COCCc1c(O)n[nH]c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.40
SMN1; SMN2 Q16637 7/20 0.38
LMNA P02545 6/20 0.38
ATM Q13315 1/20 0.37
HSD17B10 Q99714 5/20 0.36
GAA P10253 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 5/20 0.35
HTT P42858 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TSHR P16473 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13450800 0.80 SMN1; SMN2 (0.56) SMN1; SMN2LMNAATMHSD17B10GAA
SCHEMBL9025654 0.75 HCAR2 (0.40) HCAR2SMN1; SMN2LMNAATMKDM4E
SCHEMBL16846497 0.72 DYRK1A (0.39) HCAR2SMN1; SMN2LMNAHSD17B10GAA
SCHEMBL22315310 0.71 SMN1; SMN2 (0.63) SMN1; SMN2LMNAHSD17B10GAAMEN1
SCHEMBL20470813 0.69 HCAR2 (0.40) HCAR2SMN1; SMN2LMNAHSD17B10GAA
Hydrochloric Acid SCHEMBL9125490 0.69 SMN1; SMN2 (0.61) SMN1; SMN2LMNAATMHSD17B10GAA
SCHEMBL8514383 0.67 MEN1 (0.42) HCAR2LMNAGAAMEN1KMT2A
SCHEMBL19787513 0.65 HCAR2 (0.36) HCAR2LMNAHTTTSHR
SCHEMBL26977763 0.64 CASP1 (0.33) HCAR2ATMALDH1A1CYP2D6
SCHEMBL3770602 0.64 TAAR1 (0.42) SMN1; SMN2LMNAATMGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119421709-A Indazole-containing macrocyclic compounds and uses thereof 荣山医药股份有限公司 2025-02-11 CN disclosed